ischemic cerebrovascular attack.
Conditions
Interventions
Intervention 1: "Intervention group 1": patients entering the study who are treated with aspirin 80 mg once a day and placebo once a day for 21 days. Intervention 2: "Intervention group 2": patients e
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Over the age of 18 years individuals with acute ischemic stroke symptoms of disabling with NIHSS less than 5 which are not prohibited for receiving venous thrombolysis and double antiplatelet (aspirin and clopidogrel combination) according to the protocol.
Exclusion criteria
Exclusion criteria: Patients with atrial fibrillation(AF) rhythm A patient who is already on dual antiplatelet therapy ICH (intracranial hemorrhage) symptomatic after receiving intravenous thrombolysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the treatment effect of aspirin and clopidogrel and aspirin alone in ischemic stroke patients after intravenous thrombolytic therapy. Timepoint: 24 hours later, 3, 7 and 90 days after the stroke, evaluations are done. Method of measurement: Brain CT scan, modified ranking scale (mRS), neurology specialist visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahram Zarmehri
Mashhad University of Medical Sciences
Outcome results
None listed